Submitted by Anonymous (not verified) on 17 July 2025 - 14:46
Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 13, Status: Authorised